David Effinger

402 total citations
15 papers, 250 citations indexed

About

David Effinger is a scholar working on Molecular Biology, Physiology and Immunology. According to data from OpenAlex, David Effinger has authored 15 papers receiving a total of 250 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Molecular Biology, 6 papers in Physiology and 6 papers in Immunology. Recurrent topics in David Effinger's work include Diet and metabolism studies (6 papers), Extracellular vesicles in disease (4 papers) and Immune cells in cancer (4 papers). David Effinger is often cited by papers focused on Diet and metabolism studies (6 papers), Extracellular vesicles in disease (4 papers) and Immune cells in cancer (4 papers). David Effinger collaborates with scholars based in Germany, Slovakia and Italy. David Effinger's co-authors include Simone Kreth, Max Hübner, Simon Hirschberger, Gabriele Strauß, Friedrich-Wilhelm Kreth, Ting Wu, Tim Rahmel, Niklas Thon, Tingting Wu and Maximilian Muenchhoff and has published in prestigious journals such as Scientific Reports, International Journal of Molecular Sciences and Critical Care Medicine.

In The Last Decade

David Effinger

15 papers receiving 245 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
David Effinger Germany	10	100	93	62	57	24	15	250
Simon Hirschberger Germany	9	109 1.1×	145 1.6×	78 1.3×	125 2.2×	16 0.7×	14	317
Ji Sun Moon South Korea	9	121 1.2×	135 1.5×	109 1.8×	44 0.8×	14 0.6×	16	351
Karin Garrie United Kingdom	3	47 0.5×	211 2.3×	99 1.6×	38 0.7×	25 1.0×	3	322
Arisa Ochi Japan	11	95 0.9×	200 2.2×	34 0.5×	39 0.7×	10 0.4×	15	329
Julian Roos Germany	10	85 0.8×	163 1.8×	35 0.6×	139 2.4×	12 0.5×	18	357
Kristine M. Morin United States	4	51 0.5×	58 0.6×	67 1.1×	38 0.7×	12 0.5×	4	274
Amin Khalifeh‐Soltani United States	11	74 0.7×	103 1.1×	83 1.3×	22 0.4×	31 1.3×	12	299
Juan R. Acosta Sweden	9	266 2.7×	135 1.5×	66 1.1×	32 0.6×	8 0.3×	10	435
Kaitlin McKernan United States	6	101 1.0×	103 1.1×	68 1.1×	16 0.3×	10 0.4×	7	277
Karima Drareni France	6	98 1.0×	131 1.4×	81 1.3×	21 0.4×	9 0.4×	8	312

Countries citing papers authored by David Effinger

Since Specialization

Citations

This map shows the geographic impact of David Effinger's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David Effinger with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David Effinger more than expected).

Fields of papers citing papers by David Effinger

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by David Effinger. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David Effinger. The network helps show where David Effinger may publish in the future.

Co-authorship network of co-authors of David Effinger

This figure shows the co-authorship network connecting the top 25 collaborators of David Effinger. A scholar is included among the top collaborators of David Effinger based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with David Effinger. David Effinger is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

15 of 15 papers shown

Muenchhoff, Maximilian, Johannes C. Hellmuth, Clemens Scherer, et al.. (2024). CD74 is a functional MIF receptor on activated CD4+ T cells. Cellular and Molecular Life Sciences. 81(1). 296–296. 21 indexed citations

Hirschberger, Simon, et al.. (2024). The impact of a ketogenic diet on weight loss, metabolism, body composition and quality of life. iScience. 27(12). 111291–111291. 1 indexed citations

Rahmel, Tim, David Effinger, Thilo Bracht, et al.. (2024). An open-label, randomized controlled trial to assess a ketogenic diet in critically ill patients with sepsis. Science Translational Medicine. 16(755). eadn9285–eadn9285. 8 indexed citations

Effinger, David, Simon Hirschberger, Burkhard Schütz, et al.. (2023). A ketogenic diet substantially reshapes the human metabolome. Clinical Nutrition. 42(7). 1202–1212. 26 indexed citations

Li, Lei, Ludwig Christian Hinske, Roland Tomasi, et al.. (2022). A Functional Network Driven by MicroRNA-125a Regulates Monocyte Trafficking in Acute Inflammation. International Journal of Molecular Sciences. 23(18). 10684–10684. 2 indexed citations

Hübner, Max, Lei Li, David Effinger, et al.. (2022). Cell-Crossing Functional Network Driven by microRNA-125a Regulates Endothelial Permeability and Monocyte Trafficking in Acute Inflammation. Frontiers in Immunology. 13. 826047–826047. 5 indexed citations

Hirschberger, Simon, David Effinger, Maximilian Muenchhoff, et al.. (2022). Ketone Bodies Improve Human CD8+ Cytotoxic T-Cell Immune Response During COVID-19 Infection. Frontiers in Medicine. 9. 923502–923502. 19 indexed citations

Hirschberger, Simon, Gabriele Strauß, David Effinger, et al.. (2021). Very‐low‐carbohydrate diet enhances human T‐cell immunity through immunometabolic reprogramming. EMBO Molecular Medicine. 13(8). e14323–e14323. 64 indexed citations

Rahmel, Tim, Max Hübner, Björn Koos, et al.. (2020). Impact of carbohydrate-reduced nutrition in septic patients on ICU: study protocol for a prospective randomised controlled trial. BMJ Open. 10(7). e038532–e038532. 9 indexed citations

10.

Hübner, Max, Nicholas Moellhoff, David Effinger, et al.. (2020). MicroRNA-93 acts as an “anti-inflammatory tumor suppressor” in glioblastoma. Neuro-Oncology Advances. 2(1). vdaa047–vdaa047. 10 indexed citations

11.

Hübner, Max, David Effinger, Ting Wu, et al.. (2020). The IL-1 Antagonist Anakinra Attenuates Glioblastoma Aggressiveness by Dampening Tumor-Associated Inflammation. Cancers. 12(2). 433–433. 17 indexed citations

12.

Hirschberger, Simon, Max Hübner, Gabriele Strauß, et al.. (2019). Identification of suitable controls for miRNA quantification in T-cells and whole blood cells in sepsis. Scientific Reports. 9(1). 15735–15735. 12 indexed citations

13.

Hübner, Max, Roland Tomasi, David Effinger, et al.. (2019). Myeloid-Derived Suppressor Cells Mediate Immunosuppression After Cardiopulmonary Bypass. Critical Care Medicine. 47(8). e700–e709. 15 indexed citations

14.

Hübner, Max, David Effinger, Ting Wu, et al.. (2018). Intronic miR-744 Inhibits Glioblastoma Migration by Functionally Antagonizing Its Host Gene MAP2K4. Cancers. 10(11). 400–400. 40 indexed citations

15.

Hübner, Max, Gabriele Strauß, David Effinger, et al.. (2015). IMPS-15PDT-TREATED GBM CELLS INCREASE EFFECTOR FUNCTIONS OF HUMAN CD8+ T-CELLS. Neuro-Oncology. 17(suppl 5). v116.2–v116. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact